Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 2 | |
Outperform | 4 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 6 analysts offering 12 month price targets for Kiniksa Pharmaceuticals Ltd have a median target of 35.00, with a high estimate of 40.00 and a low estimate of 32.00. The median estimate represents a 65.96% increase from the last price of 21.09.
High | 89.7% | 40.00 |
Med | 66.0% | 35.00 |
Low | 51.7% | 32.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 03, 2025.
Average growth rate | -62.00% |
Average growth rate | -22.57% |
More ▼
Revenue history & estimates in USD
Average growth rate | +14.54% |
Average growth rate | +164.66% |
More ▼